Search results
21 maj 2015 · Amends the Public Health Service Act to direct the Department of Health and Human Services to provide for the planning and implementation of an education campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction, prostheses, and other options, with a focus on informing patients ...
In 2015, an estimated 231,840 new cases of invasive breast cancer are expected to be diagnosed among women in the United States 1 . Less than half of all women requiring a mastectomy are currently offered breast reconstruction surgery 2 .
The Breast Cancer Patient Education Act of 2015 requires the Secretary of Health and Human Services to plan and implement an education campaign to inform breast cancer patients about the availability and coverage of breast reconstruction and other available alternatives post-mastectomy.
25 paź 2024 · Topics covered include: the breast and breast cancer, risk factors, diagnosis and staging, treatment, survivorship, integrative and complementary therapy, support, specific populations and resources. After Early Breast Cancer- Signs and Symptoms of Metastatic Breast Cancer View PDF
7 wrz 2023 · Breast cancer is the most common female cancer in the United States, the second most common cause of cancer death in women (after lung cancer). When found and treated early, breast cancer is most often curable. Breast cancer deaths have decreased by one-third or more over the past three decades.
ASPS’s chief legislative priority, the Breast Cancer Patient Education Act, was signed into law by President Obama in December 2015. This law will ensure that women are informed of their reconstructive options prior to mastectomy as guaranteed under the Women’s Health and Cancer Rights Act of 1998. The law requires health plans that cover ...
The European guidelines on breast cancer screening and diagnosis are intended to provide up-to-date, evidence-based recommendations on breast cancer screening and diagnosis. Their development is reported transparently so that they can be implemented across Europe and beyond. They offer clear, objective and independent guidance on breast cancer ...
